. Vascular permeability in mice. Mice were randomly assigned to four groups (n = 30 per group) and exposed to 10 ppb of arsenic in drinking water supplied by arsenic trioxide (ATO), arsenic pentoxide (arsenate), or roxarsone or maintained on tap water for 4 weeks. (A) Changes in body weight for each group are expressed as average percentage (%) relative to initial weight (n = 20 per group). Gross images of (B) colons and (D) feet are shown (bars = 1 cm). Evans blue dye extracted from (C) colons or (E) feet were measured (n = 3 per group). (F) Water consumption is shown (5 mice per cage, n = 6 cages per group). (G) Water consumption of singly-housed mice (1 mouse per cage, n = 5 cages per group) and group-housed mice (5 mice per cage, n = 1 cage per group) are shown. The data are presented as the mean ± standard deviation (SD). Figure S2 . Total arsenic and arsenic species in the aortas. Mice were randomly assigned to four groups (n = 30 per group) and exposed to 10 ppb of arsenic by adding arsenic trioxide (ATO), arsenic pentoxide (arsenate), or roxarsone or maintained on tap water for 4 weeks. (A) The concentrations of total arsenic (tAs) in the aortas were measured (n = 3 per group). (B) The representative chromatograms of arsenic species in the aortas and the mixed arsenic species standard solution (2 ppb), including sodium arsenite [iAs(III)], sodium arsenate [iAs(V)], monomethylarsenic disodium [MMA(V)] and dimethylarsenic acid [DMA(V)], are shown. (C)
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. Sequences of primers for qPCR. Table S2 . Effects of ATO on apoptosis in HUVECs. Table S3 . Effects of ATO on cell cycle distribution in HUVECs.
Figure S1. Vascular permeability in mice. Mice were randomly assigned to four groups (n = 30 per group) and exposed to 10 ppb of arsenic in drinking water supplied by arsenic trioxide (ATO), arsenic pentoxide (arsenate), or roxarsone or maintained on tap water for 4 weeks. (A) Changes in body weight for each group are expressed as average percentage (%) relative to initial weight (n = 20 per group). Gross images of (B) colons and (D) feet are shown (bars = 1 cm). Evans blue dye extracted from (C) colons or (E) feet were measured (n = 3 per group). (F) Water consumption is shown (5 mice per cage, n = 6 cages per group). (G) Water consumption of singly-housed mice (1 mouse per cage, n = 5 cages per group) and group-housed mice (5 mice per cage, n = 1 cage per group) are shown. The data are presented as the mean ± standard deviation (SD). Figure S2 . Total arsenic and arsenic species in the aortas. Mice were randomly assigned to four groups (n = 30 per group) and exposed to 10 ppb of arsenic by adding arsenic trioxide (ATO), arsenic pentoxide (arsenate), or roxarsone or maintained on tap water for 4 weeks. The concentrations of arsenic species in aortas of mice exposed to ATO (10 ppb of arsenic, 4 weeks) were calculated (n = 3 per group). The data are presented as the mean ± standard deviation (SD).
Figure S3
. Vascular permeability in ApoE -/-mice treated with 10 ppb arsenic trioxide (ATO). Two groups (n = 10 per group) of either male ApoE knockout (ApoE -/-) mice or male C57BL/6J mice (wild type, WT) were maintained on tap water supplemented with or without ATO (10 ppb of arsenic) for 4 weeks. Mice were injected intravenously with (A-C) Evans blue or (D-E) FITC-conjugated albumin from bovine serum (FITC-BSA). Representative images of (A) mice or (B) aortas are shown (bars = 1 cm). (C) Evans blue dye in aortas were extracted and measured (n = 3 per group). (D) Representative images of FITC-BSA in aortic sections are shown (bars = 400 μm for top images and 100 µm for bottom images). (E) Relative fluorescence intensity of FITC-BSA in aortic sections were quantified by ImageJ (3 sections per mouse; n = 3 mice per group). (F) Changes in body weight for each group are expressed as average percentage (%) relative to initial weight (n = 10 per group). (G) Water consumption is shown (5 mice per cage, n = 2 cages per group). The data are presented as the mean ± standard deviation (SD). 
Figure S6. Effects of ATO on interaction of CAST and CAPNs in HUVECs.
Human umbilical vein endothelial cells (HUVECs) were treated with arsenic trioxide (ATO, 0.13 μM of arsenic) for indicated times. (A) Co-IP was employed by using Dynabeads Protein A binding with anti-CAST antibody, followed by western blotting to detected CAST, CAPN1 and CAPN2. (B-C) Relative protein levels were quantified by ImageJ (n = 3 per group) and whole cell lysates samples were normalized to β-actin. The data are presented as the mean ± standard deviation (SD).
Figure S7. Effects of arsenic compounds on cell viability and CAPN activation in HUVECs.
Human umbilical vein endothelial cells (HUVECs) were treated with different doses of arsenicals (0-8.32 μM of arsenic, 24 h), including arsenate pentoxide (arsenate) or roxarsone. (A) Cell viability was detected by Cell Counting Kit (CCK-8) assay (n = 3 per group). HUVECs were treated with arsenate or roxarsone (0.13 μM of arsenic) for (B) 12 hours or (C-G) 24 hours. (B) Effects on CAPN activity were measured (n = 3 per group). (C) Relative mRNA levels of CAPNs and calpastatin (CAST) were quantified by qPCR (n = 3 per group). (D) The protein levels were analyzed by western blotting and relative protein levels in (E) control group, (F) arsenate group and (G) roxarsone group normalized to β-actin are shown (n = 3 per group). The data are presented as the mean ± standard deviation (SD). Note: Human umbilical vein endothelial cells (HUVECs) were seeded in triplicate in 6-well-plates and treated with arsenic trioxide (ATO, 0-4.16 μM of arsenic) for 24 h. Cell cycle was evaluated by PI staining. The data are presented as the mean ± standard deviation (SD).
Figure S1. Vascular permeability in mice. Mice were randomly assigned to four groups (n = 30 per group) and exposed to 10 ppb of arsenic in drinking water supplied by arsenic trioxide (ATO), arsenic pentoxide (arsenate), or roxarsone or maintained on tap water for 4 weeks. The concentrations of arsenic species in aortas of mice exposed to ATO (10 ppb of arsenic, 4 weeks) were calculated (n = 3 per group). The data are presented as the mean ± standard deviation (SD). Cellular distribution of CAPN-1 was detected using rabbit polyclonal antibody followed by Cy3-labelled goat anti-rabbit-IgG antibody. Nuclei were counterstained with DAPI. Representative images are shown (bars = 20 μm) and arrows indicate foci of CAPN-1 in membrane. The data are presented as the mean ± standard deviation (SD).
